References
- Curtis, J.R., Patkar, N., Xie, A., Martin, C., Allison, J.J., Saag, M., Shatin, D., Saag, K.G. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum. 2007, 56, 1125–1133.
- Kane, D., Balint, P.V., Wood, F., Sturrock, R.D. Early diagnosis of pyomyositis using clinic based ultrasonography in a patient receiving infliximab therapy for Behcet’s disease. Rheumatology (Oxford) 2003, 42, 261.
- Agarwal, P.K., Gallaghar, M., Murphy, E., Virdi, M. Endogenous endophthalmitis in a rheumatoid patient on tumor necrosis factor alpha blocker. Indian J. Ophthalmol. 2007, 55, 230–232.
- Le Goff, B., Vabres, B., Cochereau, I., Bouvard, B., Lamirel, C., Maugars, Y., Berthelot, J.M. Eye loss by exogenous endophthalmitis following anti-tumor necrosis factor therapy: a report of 3 cases. J. Rheumatol. 2009, 36, 202–203.
- Montero, J.A., Ruiz-Moreno, J.M., Rodríguez, A.E., Ferrer, C., Sanchis, E., Alio, J.L. Endogenous endophthalmitis by Propionibacterium acnes associated with leflunomide and adalimumab therapy. Eur. J. Ophthalmol. 2006, 16, 343–345.
- Stewart, M.W., Alvarez, S., Ginsburg, W.W., Shetty, R., McLain, W.C., Sleater, J.P. Visual recovery following Mycobacterium chelonae endophthalmitis. Ocul. Immunol. Inflamm. 2006, 14, 181–183.
- Fonollosa, A., Segura, A., Giralt, J., Garcia-Arumi, J. Tuberculous uveitis after treatment with etanercept. Graefes Arch. Clin. Exp. Ophthalmol. 2007, 245, 1397–1399.
- Aggio, F.B., Farah, M.E., de Melo, G.B., d’Azevedo, P.A., Pignatari, A.C., Höfling-Lima, A.L. Acute endophthalmitis following intravitreal bevacizumab (Avastin) injection. Eye (Lond). 2007, 21, 408–409.
- Roos, J.C., Ostor, A.J. Orbital cellulitis in a patient receiving infliximab for ankylosing spondylitis. Am. J. Ophthalmol. 2006, 141, 767–769.
- Khalil, A., Gonzalez, F., El Riachy, E., Lucidarme, D., Filoche, B. Severe ocular bacterial infection associated with pegylated interferon and ribavirin treatment for hepatitis C. Gastroenterol. Clin. Biol. 2005, 29, 1187–1188.
- Mason, J.O. 3rd, White, M.F., Feist, R.M., Thomley, M.L., Albert, M.A., Persaud, T.O., Yunker, J.J., Vail, R.S. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection. Retina (Philadelphia, Pa.) 2008, 28, 564–567.
- Kopel, A.C., Carvounis, P.E., Holz, E.R. Bacillus cereus endophthalmitis following intravitreous bevacizumab injection. Ophthalmic Surg. Lasers Imaging 2008, 39, 153–154.
- Pilli, S., Kotsolis, A., Spaide, R.F., Slakter, J., Freund, K.B., Sorenson, J., Klancnik, J., Cooney, M. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am. J. Ophthalmol. 2008, 145, 879–882.
- Moshfeghi, A.A. Rate of endophthalmitis after anti-VEGF intravitreal injection. Retina Today 2008, 75–76.
- Jonas, J.B., Spandau, U.H., Rensch, F., Von Baltz, S., Schlichtenbrede, F. Infectious and noninfectious endophthalmitis after intravitreal bevacizumab. J. Ocul. Pharmacol. Ther. 2007, 23, 240–242.
- Lazzeri, D., Lazzeri, S., Figus, M., Tascini, C., Bocci, G., Colizzi, L., Giannotti, G., Lorenzetti, F., Gandini, D., Danesi, R., Menichetti, F., Del Tacca, M., Nardi, M., Pantaloni, M. Periorbital necrotizing fasciitis. Br. J. Ophthalmol. 2010 Sep 9, [Epub ahead of print].